Mgr. Štěpán Havel
Researcher I, Department of Chemistry
correspondence Address:
Kotlářská 267/2, 611 37 Brno
e‑mail: |
---|
Total number of publications: 15
2025
-
Discovery of new inhibitors of nuclease MRE11
European Journal of Medicinal Chemistry, year: 2025, volume: 285, edition: March, DOI
2024
-
Novel casein kinase 1 alpha inhibitors for the treatment of resistant AML and solid tumors
Year: 2024, type: Conference abstract
2023
-
Substituted aminothiazoles as inhibitors of nucleases
Publisher: United States Patent and Trademark Office, state: United States of America, patent's number: US11584742, year: 2023
-
Substituted aminothiazoles as inhibitors of nucleases
Publisher: Israel Patent Office, state: Israel, patent's number: IL277866, year: 2023
2022
-
Substituted aminothiazoles as inhibitors of nucleases
Publisher: IP Australia, state: Australia, patent's number: AU2019256670, year: 2022
-
Substituted propanamides as inhibitors of nucleases
Publisher: United States Patent and Trademark Office, state: United States of America, patent's number: US11453663, year: 2022
-
Substituted propanamides as inhibitors of nucleases
Publisher: IP Australia, state: Australia, patent's number: AU2019256672, year: 2022
-
ヌクレアーゼの阻害剤としての置換アミノチアゾール
Publisher: Japan Patent Office (JPO), state: Japan, patent's number: JP7175031, year: 2022
-
ヌクレアーゼの阻害剤としての置換プロパンアミド
Publisher: Japan Patent office, state: Japan, patent's number: JP7148999, year: 2022
2021
-
SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES
Publisher: European Patent Office, state: Germany, patent's number: EP3556755B1, year: 2021